TG
TPG GP A, LLC
LifeStance Health Group, Inc. LifeStance Health Group, Inc. McAfee Corp. Trevi Therapeutics, Inc. Cushman & Wakefield plc Progyny, Inc. Nerdy Inc. Amneal Pharmaceuticals, Inc. Super League Gaming, Inc. Nextracker Inc. AG Twin Brook Capital Income Fund Life Time Group Holdings, Inc. Bicara Therapeutics Inc. Ceribell, Inc. ServiceTitan, Inc. Sionna Therapeutics, Inc. TPG Twin Brook Capital Income Fund €108m
▲ Purchases (3 ops.)
Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by TPG GP A, LLC. Insider active across 17 companies, notably LifeStance Health Group, Inc.. Aggregated, 49 reports have been recorded. Breakdown: 3 buys · 38 sells. Total volume traded: €1.5bn. History available since 28 April 2022. The latest transaction was disclosed on 12 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations 49 total
3,966,554.017 shares Common shares of beneficial interest, Class I SEC:0001999371-26-014057:0
Ideal exit: 26 Mar 2027 (T+270) 202,368 shares Common Stock SEC:0001999371-26-013926:0
28,281,943 shares @ US$8.02 6.62% mcap 100.0% of flow Common Stock SEC:0001999371-26-010737:0
28,281,943 shares @ US$8.02 7.06% mcap 100.0% of flow Common Stock SEC:0001999371-26-010737
3,976,000.859 shares @ US$25.1509 100.0% of flow Common shares of beneficial interest, Class I SEC:0001999371-25-021397:0
Ideal exit: 25 Sept 2026 (T+270) 7,067,299 shares @ US$30.13 61.5% of flow Class A Common Stock SEC:0001999371-25-002436:0
4,875,547 shares Common Stock SEC:0001999371-25-001562:0
5,107,469 shares Class A Common Stock SEC:0001999371-24-015486:0
2,757,266 shares 0Class A Common Stock SEC:0001839882-24-039261:0
2,678,525 shares @ US$24.18 18.2% of flow Class A Common Stock SEC:0001839882-24-038923:0
3,587,154 shares Common Stock SEC:0001999371-24-013486:0
1,960,425 shares Common Stock SEC:0001999371-24-012102:0
3,575,000 shares @ US$20.88 20.4% of flow Class A Common Stock SEC:0001999371-24-010262:0
982,885.989 shares @ US$25.44 100.0% of flow Common shares of beneficial interest, Class I SEC:0001913724-24-000067:0
Ideal exit: 28 Mar 2025 (T+270) 14,573,017 shares @ US$5.8906 29.1% of flow Common Stock SEC:0001999371-24-006780:0
17,098,001 shares @ US$11.00 47.7% of flow Ordinary Shares SEC:0001999371-24-006606:0
7,734,954 shares @ US$9.74 19.1% of flow Ordinary Shares SEC:0001999371-24-003047:0
4,284,166 shares Class A Common Stock SEC:0001999371-24-001660:0
10,000,000 shares @ US$7.63 19.5% of flow Ordinary Shares SEC:0001839882-23-030319:0
2,400,000 shares 0Class A Common Stock SEC:0001387131-23-011713:0
8,461,824 shares @ US$0.20 84.3% of flow Common Stock SEC:0001387131-23-009957:0
2,900,000 shares @ US$41.08 78.7% of flow Common Stock SEC:0001387131-23-009505:0
69,760 shares @ US$0.3785 1.3% of flow Common Stock SEC:0001387131-23-009014:0
20,601 shares @ US$0.3506 0.4% of flow Common Stock SEC:0001839882-23-019163:0
2,885 shares @ US$0.3507 0.0% of flow Common Stock SEC:0001387131-23-008599:0
25 of 49 declarations
Load more (24 remaining) About TPG GP A, LLC TPG GP A, LLC is a director and insider at LifeStance Health Group, Inc., McAfee Corp., Trevi Therapeutics, Inc., and Cushman & Wakefield plc.